on IChemLabs, LLC.
Collaborative Drug Discovery Integrates iChemLabs' IUPAC Naming Technology into CDD Vault
BURLINGAME, CA / ACCESSWIRE / June 17, 2024 / Collaborative Drug Discovery (CDD) has announced the integration of iChemLabs' industry-leading IUPAC naming technologies into CDD Vault, enhancing its cheminformatics and chemical structure analysis capabilities. This enhancement is made possible through the licensing of the ChemDoodle Java Application Programming Interface (API).
The ChemDoodle API, utilized globally by thousands of institutions, will now enable CDD Vault users to generate accurate IUPAC names for complex chemical structures. This streamlines the process of chemical data management, reducing manual data entry and the risk of human error.
The integration offers several key benefits: precise IUPAC naming, seamless workflows, enhanced data integrity, and a user-friendly interface. Researchers will find it easier to identify and document chemical structures, improving overall efficiency and reliability.
Both CDD and iChemLabs express their optimism about the collaboration. "Our ChemDoodle API will offer robust and precise chemical informatics capabilities," said Kevin Theisen, President of iChemLabs. Barry Bunin, CEO of CDD, echoed similar sentiments, emphasizing the positive impact on chemical data management for researchers worldwide.
The new IUPAC naming features are now available to all CDD Vault users. For more information, contact CDD through their provided channels.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all IChemLabs, LLC. news